Not a good buy right now for an impatient entry: price is pushing into near-term resistance (R1 50.67, R2 ~51.35), so upside is limited versus downside back to the pivot (49.59).
Trend is bullish, but there’s no Intellectia buy signal today and options activity shows low real-time conviction (zero volume).
With no fresh news catalyst this week and a mixed short-term pattern outlook (positive next week, negative next month), the current risk/reward at resistance favors waiting rather than buying immediately.
Technical Analysis
Trend/Momentum: Bullish structure with SMA_5 > SMA_20 > SMA_200 and MACD histogram positive and expanding (0.0122), indicating an ongoing uptrend.
RSI: RSI_6 at 62.09 is neutral-to-slightly-warm (not overbought), so momentum can continue, but it’s not a deep-value entry.
Levels: Pivot ~49.59 (key “line in the sand”). Immediate resistance at R1 ~50.67 and R2 ~51.35; support at S1 ~48.50.
Pattern-based expectation: Similar-pattern stats suggest +3.93% next week but -1.86% next month, implying potential near-term pop followed by mean reversion.
Sentiment (positioning): Open Interest Put-Call Ratio = 0.47 (more calls than puts), typically a mildly bullish positioning signal.
Activity: Option volume is 0 today (Put-Call Volume Ratio = 0.0), so the market isn’t actively expressing a strong near-term view via options right now.
Volatility: IV 30d ~35.16 vs historical vol ~15.08, with IV percentile ~77.78 (elevated vs its own history). This suggests the market is pricing in more uncertainty than usual (often seen around event windows), but without volume it’s not a high-conviction signal.
Technical Summary
Sell
7
Buy
5
Positive Catalysts
showed strong YoY growth in revenue and a sharp rebound in profitability metrics.
Neutral/Negative Catalysts
Price is near resistance (R1/R2 zone), reducing immediate upside versus downside back toward the pivot.
No news flow in the last week to act as a clear upside catalyst.
Recent trend: Both BMO Capital and RBC Capital raised price targets on 2025-11-10 (BMO to C$72 from C$69; RBC to C$76 from C$70) and reiterated Outperform.
Wall Street “pros” view: Upward target revisions + maintained Outperform ratings suggest improving confidence in earnings durability and outlook.
Wall Street “cons” view: With the stock already in a bullish trend and near resistance, upside may be more incremental unless new catalysts emerge.
Wall Street analysts forecast EMA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMA is 51.11 USD with a low forecast of 48.95 USD and a high forecast of 54.71 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast EMA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMA is 51.11 USD with a low forecast of 48.95 USD and a high forecast of 54.71 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
4 Hold
0 Sell
Moderate Buy
Current: 50.210
Low
48.95
Averages
51.11
High
54.71
Current: 50.210
Low
48.95
Averages
51.11
High
54.71
BMO Capital
NULL -> Outperform
maintain
$69 -> $72
AI Analysis
2025-11-10
Reason
BMO Capital
Price Target
$69 -> $72
AI Analysis
2025-11-10
maintain
NULL -> Outperform
Reason
BMO Capital raised the firm's price target on Emera to C$72 from C$69 and keeps an Outperform rating on the shares.
RBC Capital
NULL -> Outperform
maintain
$70 -> $76
2025-11-10
Reason
RBC Capital
Price Target
$70 -> $76
2025-11-10
maintain
NULL -> Outperform
Reason
RBC Capital raised the firm's price target on Emera to C$76 from C$70 and keeps an Outperform rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for EMA
